AveXis (AVXS) - Management Comments

AveXis (AVXS) – Management Comments

Apr 25, 2018 08:05 AM AveXis (AVXS) Reports First Patient Dosed in Phase 3 Trial of AVXS-101 in Pre-Symptomatic SMA Types 1, 2 and 3
Apr 24, 2018 04:08 PM AveXis (AVXS) Presents Initial Data from Pivotal U.S. Trial for SMA Type 1 and 24-Month Follow-Up Data from Phase 1 Trial of AVXS-101 in SMA Type 1
Mar 27, 2018 08:15 AM
Mar 13, 2018 04:02 PM
Jan 30, 2018 04:25 PM
Jan 16, 2018 07:21 AM
Jan 8, 2018 08:10 AM
Jan 8, 2018 08:05 AM
Jan 4, 2018 04:07 PM
Jan 4, 2018 04:01 PM
Dec 13, 2017 04:01 PM
Oct 3, 2017 08:05 AM
Sep 29, 2017 07:03 AM
Jun 7, 2017 04:01 PM
Apr 25, 2017 10:35 AM
Mar 16, 2017 04:10 PM
Feb 6, 2017 08:04 AM
Oct 12, 2016 09:16 AM
Oct 10, 2016 06:56 AM
May 16, 2016 08:06 AM
May 6, 2016 03:13 PM
Apr 25, 2016 12:37 PM